Status:
COMPLETED
Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Immunity Factors in Cancer Colon Patients
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Surgery is the primary treatment for colon cancer. However, the rate of recurrence or metastasis in colon cancer can be as high as 30%, even in stages 1 and 2 . Most colon cancer-related deaths are ca...
Eligibility Criteria
Inclusion
- Age 20-70 yrs.
- ASA class I and II
- Elective open surgery for non-metastatic cancer colon stage I,II
Exclusion
- Patient refusal
- Known allergy to the study medications
- Patients with compromised immune function ( associated blood diseases, immunosuppressive drugs, chemotherapeutic agents, corticosteroids)
- Contraindications to epidural insertion e.g. infection at insertion site and coagulopathy
Key Trial Info
Start Date :
April 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04518579
Start Date
April 15 2018
End Date
August 1 2020
Last Update
August 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 71511